Use of automated medication adherence monitoring in bipolar disorder research: Pitfalls, pragmatics, and possibilities

Therapeutic Advances in Psychopharmacology

Volumn 5, Issue 2, 2015, Pages 76-87

  Levin, Jennifer B ^a   Sams, Johnny ^a   Tatsuoka, Curtis ^b   Cassidy, Kristin A ^a   Sajatovic, Martha ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

bipolar disorder; medication adherence; randomized controlled trial

Indexed keywords

PSYCHOTROPIC AGENT;

AFRICAN AMERICAN; ARTICLE; AUTOMATION; BIPOLAR DISORDER; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG COST; DRUG MONITORING; ELECTRONIC DATA INTERCHANGE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION EVENT MONITORING SYSTEM; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT PLANNING;

EID: 84997858599     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125314566807     Document Type: Article

References (34)

1. American Psychiatric Association (2006) American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Arlington, VA: American Psychiatric Publishing.
2. Arnet I. Walter P. Hersberger K. (2013) Polymedication Electronic Monitoring System (POEMS) – a new technology for measuring adherence. Front Pharmacol 4: 26.
3. Badiee J. Riggs P. Rooney A. Vaida F. Grant I. Atkinson J. et al. (2012) Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS 26: 388–394.
4. Bova C. Fennie K. Knafl G. Dieckhaus K. Watrous E. Williams A. (2005) Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav 9: 103–110.
5. Byerly M. Fisher R. Whatley K. Holland R. Varghese F. Carmody T. et al. (2005) A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 133: 129–133.
6. Colom F. Vieta E. Tacchi M. Sanchez-Moreno J. Scott J. (2005) Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 7(Suppl. 5): 24–31.
7. Creswell J. Clark V. Gutmann M. Hanson W. (2003) Advanced Mixed Methods Research Designs. Thousand Oaks, CA: Sage Publications.
8. Diaz E. Levine H. Sullivan M. Sernyak M. Hawkins K. Cramer J. et al. (2001) Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci 26: 325–329.
9. First M. Gibbon M. Spitzer R. Williams J. (2002) User's Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version (SCID-I for DSM-IV-TR, November 2002 Revision). East Lansing, MI: Biometrics Research.
10. Haberer J. Kahane J. Kigozi I. Emenyonu N. Hunt P. Martin J. et al. (2010) Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 14: 1340–1346.
11. Harvey N. (1991) The development and descriptive use of the Lithium Attitudes Questionnaire. J Affect Disord 22: 211–219.
12. Harvey N. Peet M. (1991) Lithium maintenance: 2. Effects of personality and attitude on health information acquisition and compliance. Br J Psychiatry 158: 200–204.
13. Hersberger K. Arnet I. (2012) Polymedication Electronic Monitoring System (POEMS) – introducing a new technology as gold standard for compliance measurement. J Patient Compliance 2: 48–49.
14. Lingam R. Scott J. (2002) Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105: 164–172.
15. Liu H. Golin C. Miller L. Hays R. Beck C. Sanandaji S. et al. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134: 968–977.
16. Medic G. Higashi K. Littlewood K. Diez T. Granström O. Kahn R. (2013) Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Neuropsychiatr Dis Treat 119–131.
17. O’Carroll R. Chambers J. Dennis M. Sudlow C. Johnston M. (2013) Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med 46: 358–368.
18. Osterberg L. Blaschke T. (2005) Adherence to medication. N Engl J Med 353: 487–497.
19. Pearson C. Simoni J. Hoff P. Kurth A. Martin D. (2007) Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav 11: 161–173.
20. Peet M. Harvey N. (1991) Lithium maintenance: 1. A standard education programme for patients. Br J Psychiatry 158: 197–200.
21. Perlick D. Rosenheck R. Clarkin J. Maciejewski P. Sirey J. Struening E. et al. (2004) Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatr Serv 55: 1029–1035.
22. Polkinghorne D. (1989) Phenomenological research methods. New York: Plenum Press.
23. Pomykacz B. Mao M. Weiss R. Teter C. (2007) A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry 15: 259–263.
24. Post R. Altshuler L. Frye M. Suppes T. Keck P. Jr McElroy S. et al. (2010) Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71: 1176–1186; quiz 1252–1253.
25. Sajatovic M. Ignacio R. West J. Cassidy K. Safavi R. Kilbourne A. et al. (2009) Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry 50: 100–107.
26. Sajatovic M. Levin J. Fuentes-Casiano E. Cassidy K. Tatsuoka C. Jenkins J. (2011) Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry 52: 280–287.
27. Sajatovic M. Velligan D. Weiden P. Valenstein M. Ogedegbe G. (2010) Measurement of psychiatric treatment adherence. J Psychosom Res 69: 591–599.
28. Samet J. Sullivan L. Traphagen E. Ickovics J. (2001) Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS Behav 5: 21–30.
29. Scott J. Pope M. (2002) Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 159: 1927–1929.
30. Svarstad B. Shireman T. Sweeney J. (2001) Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 52: 805–811.
31. Velligan D. Lam Y. Glahn D. Barrett J. Maples N. Ereshefsky L. et al. (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32: 724–742.
32. Velligan D. Weiden P. Sajatovic M. Scott J. Carpenter D. Ross R. et al. (2009) The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 70(Suppl. 4): 1–46; quiz 47–48.
33. World Health Organization (2003) Adherence to long-term therapies: evidence for action. Geneva: WHO.
34. Zeller A. Schroeder K. Peters T.J. (2007) Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care. Scand J Prim Health Care 25: 202–207.